These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6481115)

  • 41. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of lactulose in portal-systemic encephalopathy.
    Matthews SJ
    Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapy of salmonella enteritis with special reference to lactulose (author's transl)].
    Knothe H; Knapp G; Meyer M; Polanetzki U; Weber G
    Infection; 1980; 8 Suppl 3():S 294-8. PubMed ID: 6997206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Malaguarnera G; Salmeri M; Mastrojeni S; Rampello L; Pennisi G; Li Volti G; Galvano F
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):199-206. PubMed ID: 19730107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
    Lanthier PL; Morgan MY
    Gut; 1985 Apr; 26(4):415-20. PubMed ID: 3979914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lactulose therapy for chronic renal failure].
    Miyazaki M; Aoyagi K; Tojo S
    Nihon Jinzo Gakkai Shi; 1984 Aug; 26(8):1091-8. PubMed ID: 6513180
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R
    Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of lactulose in the treatment of chronic renal failure].
    Quarto di Palo F; Buccianti G; Civardi F
    Minerva Med; 1978 Feb; 69(7):455-60. PubMed ID: 634497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumatosis coli following treatment with lactulose.
    Zimmerman AL; Gupta JK; Ingegno AP
    N Y State J Med; 1979 Nov; 79(12):1896-9. PubMed ID: 292844
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
    Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
    BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient].
    Eisenburg J
    Fortschr Med; 1996 Apr; 114(12):141-6. PubMed ID: 8682429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study of the laxative effect of Lactitol as opposed to lactulose in an open, randomized comparative study].
    Heitland W; Mauersberger H
    Schweiz Rundsch Med Prax; 1988 May; 77(18):493-5. PubMed ID: 3051260
    [No Abstract]   [Full Text] [Related]  

  • 55. [Lactulose treatment in three patients with chronic portal-systemic encephalopathy].
    Tamai Y; Iwata Y; Tsuji M; Minakuchi C; Nagakawa J
    Naika Hokan; 1972 Apr; 19(4):113-8. PubMed ID: 5065961
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bifidum-milk and lactulose in the therapy of chronic liver diseases].
    Müting D; Reikowski J; Rosskopf U
    Med Welt; 1980 May; 31(22):857-60. PubMed ID: 7392944
    [No Abstract]   [Full Text] [Related]  

  • 57. [1st use of lactitol in the treatment of porto-systemic encephalopathy].
    Bircher J; Bührer M; Franz K; van Velthuijsen JA
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1306-7. PubMed ID: 7134954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment with lactulose. A low-risk alternative in various diseases].
    Reim HG; Koken M
    Fortschr Med; 1984 Dec; 102(45):1167-70. PubMed ID: 6394457
    [No Abstract]   [Full Text] [Related]  

  • 59. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients.
    Edwin D; Flynn L; Klein A; Thuluvath PJ
    Hepatology; 1999 Dec; 30(6):1363-7. PubMed ID: 10573512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypocholesterolemic effect of lactulose in man: a preliminary report.
    Conte D; Bardella MT; Bernardi R; Pasetti G; Bianchi PA
    Panminerva Med; 1977; 19(1):1-4. PubMed ID: 834472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.